We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+1.88%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$19.1B
AUM Growth
+$1.86B
Cap. Flow
+$1.66B
Cap. Flow %
8.66%
Top 10 Hldgs %
39.98%
Holding
84
New
14
Increased
25
Reduced
23
Closed
10

Top Buys

Rank Stock Value
1
PNR icon
Pentair
PNR
+$406M
2
AGN
Allergan plc
AGN
+$384M
3
DHR icon
Danaher
DHR
+$382M
4
HOUS
Anywhere Real Estate
HOUS
+$230M
5
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$186M

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$265M
2
AIG icon
American International
AIG
+$237M
3
MCK icon
McKesson
MCK
+$187M
4
HCA icon
HCA Healthcare
HCA
+$149M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$125M

Sector Composition

Rank Sector Weight
1 Healthcare 36.02%
2 Consumer Discretionary 11.4%
3 Technology 8.45%
4 Materials 7.77%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
1
Thermo Fisher Scientific
TMO
$213B
$1.38B 7.24%
11,375,667
+433,474
+4% +$52.7M
MON
2
DELISTED
Monsanto Co
MON
$1.08B 5.66%
9,618,448
+1,210,383
+14% +$142M
THC icon
3
Tenet Healthcare
THC
$17.1B
$820M 4.29%
13,812,831
– –
FLEX icon
4
Flex
FLEX
$46.9B
$724M 3.78%
93,063,783
– –
HCA icon
5
HCA Healthcare
HCA
$83.5B
$678M 3.54%
9,610,559
-2,252,083
-19% -$149M
CYH icon
6
Community Health Systems
CYH
$392M
$663M 3.46%
14,633,492
– –
HUM icon
7
Humana
HUM
$47.4B
$654M 3.42%
5,016,536
+360
+0% +$45.8K
CCI icon
8
Crown Castle
CCI
$32.6B
$650M 3.4%
8,076,490
-162,300
-2% -$12.5M
PVH icon
9
PVH
PVH
$3.59B
$498M 2.6%
4,107,352
+564,144
+16% +$66.1M
HRI icon
10
Herc Holdings
HRI
$5.45B
$495M 2.59%
6,495,311
-83,334
-1% -$7.12M
ELV icon
11
Elevance Health
ELV
$82.3B
$483M 2.52%
4,036,445
-479,355
-11% -$55M
PNR icon
12
Pentair
PNR
$10B
$461M 2.41%
10,480,827
+8,780,267
+516% +$406M
DG icon
13
Dollar General
DG
$25.4B
$441M 2.3%
7,211,315
-1,005,000
-12% -$60.2M
AGN
14
DELISTED
Allergan plc
AGN
$414M 2.17%
+1,717,858
New +$384M
ENDP
15
DELISTED
Endo International plc
ENDP
$387M 2.02%
5,658,326
+1,727,854
+44% +$114M
DHR icon
16
Danaher
DHR
$135B
$380M 1.99%
+7,439,160
New +$382M
NOV icon
17
NOV
NOV
$7.22B
$370M 1.93%
4,855,731
-436,900
-8% -$36.1M
MCK icon
18
McKesson
MCK
$96.5B
$363M 1.9%
1,866,966
-970,700
-34% -$187M
AET
19
DELISTED
Aetna Inc
AET
$356M 1.86%
4,400,035
+921,200
+26% +$75M
WOOF
20
DELISTED
VCA Inc.
WOOF
$342M 1.79%
8,686,170
-105,000
-1% -$4.05M
FOSL icon
21
Fossil Group
FOSL
$236M
$306M 1.6%
3,255,738
+582,100
+22% +$58.6M
AIG icon
22
American International
AIG
$41.4B
$298M 1.56%
5,524,198
-4,329,000
-44% -$237M
EBAY icon
23
eBay
EBAY
$48.5B
$279M 1.46%
11,689,747
– –
TWC
24
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$263M 1.38%
1,836,090
-843,270
-31% -$125M
FNF icon
25
Fidelity National Financial
FNF
$13.1B
$262M 1.37%
13,600,636
+2,853,860
+27% +$55.2M
1
2 3 4

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Glenview Capital Management held 84 positions worth $19.1B, up 11% from $17.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Glenview Capital Management deployed $1.66B of net new capital in Q3 2014, opening 14 new positions and adding to 25 existing holdings. Its largest new stake was Allergan plc: 1,717,858 shares worth $414M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was American International, an estimated $237M trimmed.

  • Glenview Capital Management's largest Q3 2014 buy was Allergan plc: 1,717,858 shares worth $414M.
  • Glenview Capital Management added most to Pentair in Q3 2014, an estimated $406M increase.
  • Glenview Capital Management's biggest Q3 2014 reduction was American International, cutting an estimated $237M.
  • Glenview Capital Management fully exited Walgreens Boots Alliance in Q3 2014, selling an estimated $265M.
  • Glenview Capital Management's ten largest holdings make up 40% of its $19.1B portfolio in Q3 2014.
  • Glenview Capital Management opened 14 new positions and closed 10 in Q3 2014.
  • Glenview Capital Management's portfolio value rose 11% quarter-over-quarter to $19.1B.

Based on Glenview Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.